IVC Filter Compensation Application

“What many cancer patients don’t know about Taxotere, however, is that the chemotherapy medication has been linked to an increased risk of hair loss (alopecia) that may become permanent, and pending Taxotere lawsuits accuse Sanofi-Aventis of failing to warn the public and healthcare providers about this risk.”

Monroe Law Group – NO FEES UNLESS YOU WIN

You pay nothing until you win your case. Monroe Law Group pays for all costs of the lawsuit up front, and if don’t win, you pay nothing! If we win, you pay a percentage of the awarded settlement.

Taxotere Lawsuits

Are you still bald after chemo? Are you hiding under a baseball cap long after your hair was supposed to grow back? Are your doctors perplexed? If so, you may be one of a growing number of people around the world who have experienced persistent chemo-induced alopecia, or hair loss.

According to Sanofi-Aventis, manufacturer of the chemotherapy drug Taxotere—used to treat breast, lung, gastric, head and neck and prostate cancer—3% of patients administered the drug could experience long-term alopecia. This figure could rise to as high as 6.3% when given in combination with the drugs Adriamycin (doxorubicin) and Cyclophosphamide, according to a study by the Rocky Mountain Cancer Centers in Colorado.

“Such an emotionally devastating long-term toxicity from this combination must be taken into account when deciding on adjuvant chemotherapy programs in women who likely will be cured of their breast cancer,” the study concludes.

Despite this recommendation, patients are not being informed of this potentially disfiguring side effect.

Taxotere and Permanent Hair Loss, Sanofi-Aventis, the company that makes Taxotere, has been accused of failing to warn about the risk of permanent hair loss until December 2015, when the FDA updated the label.

http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm212079.htm

Studies connecting Taxotere to permanent or persistent hair loss has been on the rise for years. A 2006 study by Dr. Scot Sedlacek found that 6.3% of breast cancer patients grew back less than 50% of their hair after using Taxotere when combined with Adriamycin (docorubicin) and Cytoxan (cyclophosphamide).

How Can the Monroe Law Group Help?

The Monroe Law Group is accepting Taxotere permanent and persistent hair loss cases in all 50 states. If you or loved one has been diagnosed with persistent or permanent hair loss, you should contact our expert attorneys immediately for a free, confidential case consultation. Please call 866-308-1092 or email us at intake@monroelawgroup.com to speak to one of our attorneys, or complete the free case evaluation on this page. Our cases are always free unless there is a settlement or verdict in your favor.

Taxotere Side Effects

A growing number of studies have shown that side effects of the chemotherapy drug Taxotere (docetaxel) may result in an increased risk of persistent or permanent hair loss in cancer patients taking the medication. In fact, one report conducted by the National Cancer Research Institute in November 2014 indicated that 10-15% of patients taking Taxotere, also known as docetaxel or docefrez, may experience permanent baldness as a side effect of the chemotherapy treatment. If you believe you have been adversely affected by hair loss side effects of Taxotere, contact a knowledgeable Taxotere attorney today to discuss your legal options. You may have grounds to file a product liability lawsuit against Taxotere maker Sanofi-Aventis, in order to seek fair and timely reimbursement for your losses.

Studies Linking Taxotere to Side Effects

Permanent chemotherapy-induced alopecia: case report and review of the literature.

The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs

Links to Taxotere Support Groups

Taxotears

A Head of Our Time

Did you take Taxotere, Docetaxel or Docefrez as a form of chemotherapy to treat cancer?

Taxotere is a chemotherapy medication belonging to a group of drugs called taxanes, which are designed to prevent harmful cancer cells from growing and dividing. Taxotere is currently manufactured by pharmaceutical company Sanofi-Aventis, and is commonly prescribed for the treatment of breast cancer, metastatic prostate cancer, non-small cell lung cancer, and head and neck cancer. What many cancer patients don’t know about Taxotere, however, is that the chemotherapy medication has been linked to an increased risk of hair loss (alopecia) that may become permanent, and pending Taxotere lawsuits accuse Sanofi-Aventis of failing to warn the public and healthcare providers about this risk.

When did you start taking the chemotherapy drug?

Originally approved by the U.S. Food and Drug Administration (FDA) in 2006, Taxotere has been used by millions of Americans diagnosed with breast cancer and other types of cancer over the years. The chemotherapy drug is typically administered intravenously in a hospital once every three weeks, sometimes in combination with other medications, and studies have shown that because Taxotere is designed to destroy all rapidly-growing cells, including both cancer cells and healthy cells, it may permanently destroy hair follicles, which are among the fastest-growing cells in the body. In December 2015, the FDA required that changes be made to the Taxotere drug label to include information about the potential for the chemotherapy medication to cause permanent hair loss in users.

Did you suffer permanent hair loss as a result of taking this medication?

There are about 2.8 million women in the United States with a history of breast cancer, and approximately 75% of these women have been prescribed the chemotherapy drug Taxotere, docetaxel or docefrez during the course of their cancer treatment. Although Sanofi-Aventis indicated in Taxotere’s prescribing information that “once you have completed all your treatments, hair generally grows back,” a growing body of research has indicated that baldness from Taxotere treatment may actually become permanent. In fact, while research conducted by Sanofi-Aventis estimates that the risk of permanent hair loss may occur in about 3% of patients, other studies suggest that the risk may be closer to 6%, or even as high as 10-15%.

Do you have a lawyer representing you in this matter?

The Monroe Law Group is accepting Taxotere permanent and persistent hair loss cases in all 50 states. If you or loved one has been diagnosed with persistent or permanent hair loss, you should contact our expert attorneys immediately for a free, confidential case consultation. Please call 866-308-1092 right now to speak to one of our attorneys or complete the free case evaluation on this page. Our cases are always free unless there is a settlement or verdict in your favor.

For cancer patients undergoing chemotherapy treatment with Taxotere, experiencing hair loss (alopecia) that persists long after the treatment is suspended can have devastating psychological side effects, including lowered self-esteem and diminished quality of life. If you took Taxotere for breast cancer or another type of cancer, and you have suffered persistent or permanent baldness as a result, it’s important that you have a qualified product liability lawyer on your side should you choose to pursue a legal claim against Sanofi-Aventis. With the help of an attorney who has experience handling Taxotere hair loss claims, you can ensure that your legal rights are protected, and pursue the financial compensation you deserve for your injuries and medical expenses.

There is no risk to you in consulting one of our lawyers today. Contact Monroe Law Group now by phone at 866-308-1092 or by email at intake@monroelawgroup.com to arrange for your free, no-obligation consultation.

Were you or a loved one prescribed Pradaxa in 2010 or later?

If you were prescribed the blood thinner Pradaxa (dabigatran) in 2010 through October 2015, to prevent harmful blood clots or stroke, don’t hesitate to discuss your case with us. Pradaxa has been marketed by its manufacturing company as a superior alternative to warfarin, an anticoagulant drug that has been on the market for decades, because it requires less maintenance than warfarin and is designed to have fewer side effects.

However, until late 2015, there was no approved antidote for Pradaxa, which means doctors were unable to reverse the blood thinning effects of the medication in the event of a serious internal bleeding complication.

Have you or a loved one suffered any of the following conditions during or after Pradaxa treatment?

Pradaxa is designed to reduce the risk of stroke and blood clots in patients with atrial fibrillation who do not have heart disease, which it does by inhibiting the action of the clotting protein thrombin. However, a number of serious and potentially life-threatening side effects have been linked to Pradaxa treatment recently, including:

• Internal or external bleeding requiring hospitalization
• Wrongful death

The complication most frequently associated with Pradaxa treatment is bleeding, which can be fatal, and when bleeding occurs in the brain or central nervous system, it can be just as harmful as a stroke, which is what Pradaxa is designed to prevent. In fact, just two years after it was approved by the U.S. Food and Drug Administration (FDA), Pradaxa was blamed for more than 500 patient deaths allegedly caused by uncontrollable bleeding and hemorrhaging complications.

Did a medical doctor confirm your condition or diagnosis?

According to the Institute for Safe Medication Practice’s (ISMP) QuarterWatch report, Pradaxa was one of the drugs most frequently mentioned in adverse event reports submitted to the FDA in 2011. That year, QuarterWatch gathered additional side effect data from healthcare professionals, manufacturers and medical databases, and found 3,781 serious adverse events tied to Pradaxa treatment.

If you or a loved one took Pradaxa, and experienced symptoms like bleeding, joint pain, coughing up blood, headaches, dizziness or unusual bruising, you should speak to a physician immediately. In addition to protecting your health and well-being, it is also important to obtain a diagnosis from a medical professional for any Pradaxa side effects because it may become necessary to provide the court with your medical records should your case go to trial.

Are you currently represented by an attorney regarding this matter?

When it comes to pharmaceutical drug side effects, it is extremely important to have a legal representative on your side who has experience handling product liability claims. Pradaxa maker Boehringer Ingelheim already faces thousands of drug injury lawsuits filed on behalf of consumers who believe they have been harmed by the controversial blood thinner medication. In 2014, the drug company agreed to pay $650 million to settle 4,000 state and federal lawsuits filed over complications from its blockbuster blood thinner, which the plaintiffs alleged can cause uncontrollable and potentially life-threatening bleeding events.

Would you like Monroe Law Group to contact you regarding a free case review?

All blood thinners carry a risk of internal bleeding, but being that until October 2015, Pradaxa did not have an approved reversal agent, the risk of uncontrollable bleeding complications had been found to be much higher with Pradaxa than with older anticoagulant medications. If you or a loved one took Pradaxa in 2010 or later, and have since been diagnosed with an internal bleeding injury that required hospitalization contact Monroe Law Group today at 866-308-1092 or via the form on this page to explore your possible compensation options. With our skilled legal team on your side, you can ensure that your legal rights are protected, and seek fair and timely reimbursement for your losses.

Alert: Due to statute of limitations, the time you have to pursue a claim is limited. Call us right away at 866-308-1092, email us at intake@monroelawgroup.com, or complete the form on this page now.

How Invokana Works

Invokana (canagliflozin) is an oral diabetes medication belonging to a class of widely-used drugs called sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are commonly prescribed in combination with diet and exercise as a treatment for Type 2 diabetes. Invokana was approved by the U.S. Food and Drug Administration (FDA) in 2013, and is currently manufactured by Johnson & Johnson’s Janssen Pharmaceuticals subsidiary. In individuals with Type 2 diabetes, the body is unable to properly use insulin to process sugar, and the pancreas is no longer able to keep up with the demand for insulin, which allows the amount of glucose in the bloodstream to reach dangerous levels. Invokana and other SGLT2 inhibitor drugs are designed to lower blood glucose levels by inhibiting a special protein in the kidneys, which prevents glucose from being reabsorbed into the blood and allows it to leave the body during urination instead.

Alleged Invokana Side Effects

Despite the fact that Invokana is a relatively new medication, the Type 2 diabetes drug, along with other drugs in its class, has already been linked to a potential risk of serious side effects in users. One of the most dangerous complications allegedly linked to Invokana therapy is diabetic ketoacidosis, a serious medical condition that can cause fatal swelling of the brain, severe dehydration, coma and possibly even death. Diabetic ketoacidosis (DKA) occurs when the body is no longer able to use sugar as a fuel source, either because there is too little or no insulin available. Instead, the body begins to break down fat for energy, which produces blood acids called ketones. When ketones are allowed to build up in the bloodstream, they can become toxic and cause serious medical complications.

Another potentially life-threatening side effect possibly linked to Invokana is kidney failure, believed to be connected to the action of the Type 2 diabetes drug on the kidneys in the removal of glucose via urination. Product liability lawsuits brought against Janssen Pharmaceuticals by patients who used Invokana in the past allege that the drug maker knew or should have known about the potential risk of Invokana diabetic ketoacidosis and kidney failure problems based on the way the diabetes medication is designed to function. However, consumer complaints allege that Janssen Pharmaceuticals and Johnson & Johnson failed to provide adequate warnings to the public about the risk of severe adverse events allegedly associated with the prescription diabetes drug.

Studies Linking Invokana to Complications

In May 2015, the FDA issued a drug safety communication warning about the potential link between SGTL2 inhibitors like Invokana and an increased risk of ketoacidosis, “a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization.” At that time, the FDA had identified 20 cases of ketoacidosis side effects in patients taking SGLT2 inhibitor medications from March 2013 to June 6, 2014, all of which involved hospitalization to treat the medical condition. In December 2015, the FDA updated its Invokana ketoacidosis warning, and also reported on the possible connection between treatment with SGLT2 inhibitors and serious urinary tract infections possibly leading to hospitalization and kidney failure. The Institute for Safe Medication Practices (ISMP) also weighed in on possible Invokana side effects in 2015, warning that the diabetes drug was linked to a higher-than-anticipated number of reported complications, surpassing 92% of the other medications regularly monitored by the agency.

Contact the Monroe Law Group today for expert Invokana legal representation

As more and more Type 2 diabetes patients are switched to Invokana therapy, the number of adverse events reported in connection with the SGLT2 inhibitor continues to climb. If you believe you have been adversely affected by alleged Invokana side effects, consult the knowledgeable product liability team at Monroe Law Group today for legal help. With a qualified Invokana attorney on your side, you can protect your legal rights and seek fair and timely reimbursement for your injuries and medical bills.

Alert: Due to statute of limitations, the time you have to pursue a claim is limited. Call us right away at 866-308-1092, email us at intake@monroelawgroup.com, or complete the form on this page now.

We are only currently able to accept cases for individuals who had the Mirena IUD with
a Pseudotumor Cerebri diagnosis. We are not currently accepting cases for Ortho Evra or Depo Provera use linked to Pseudotumor Cerebri. We apologize for the inconvenience.

Use of one of the most popular hormonal birth control devices on the market, Mirena IUD, may increase a woman’s chances of suffering devastating pseudotumor cerebri (PTC) complications possibly leading to swelling of the optic nerve and permanent vision loss.

If you or a loved one has been diagnosed with pseudotumor cerebri, and you believe a birth control product to be the cause, consult an experienced product liability lawyer as soon as possible to discuss your legal options. With a qualified pseudotumor cerebri attorney on your side, you can ensure that your legal rights are protected, and pursue the financial compensation you deserve for your injuries, medical expenses, and pain and suffering. The following article provides details on how to get a Pseudotumor Cerebri Diagnosis.

Pseudotumor Cerebri Described

Pseudotumor cerebri, sometimes called idiopathic intracranial hypertension (IIH) or benign intracranial hypertension (BIH), is a serious medical condition occurring when pressure inside the skull increases for no apparent reason. Symptoms of pseudotumor cerebri, which literally translates to “false brain tumor,” mimic those of a brain tumor when no tumor is present, and may include ringing in the ears, headaches behind the eyes, and brief episodes of blindness. These symptoms are caused by pressure from the buildup or poor absorption of cerebrospinal fluid in the skull, which acts as a cushion for the brain’s cortex, protecting the brain and spinal cord from injury. In patients with PTC, the symptoms are sometimes more intense following physical activity, and may worsen with sneezing or coughing, due to an increase of pressure within the skull.

Possible Causes of Pseudotumor Cerebri

The cause of most reported cases of pseudotumor cerebri remains unknown, but a possible connection has been found between PTC side effects and the use of hormonal contraceptive birth control intrauterine device Mirena IUD.

Mirena IUD (levonorgestrel) is a long-acting hormonal intrauterine device inserted into the uterus to prevent pregnancy for up to five years. The flexible, T-shaped device slowly releases the progestin levonorgestrel directly into the uterus over time, and is a popular alternative to daily birth control pills.

One of the first studies to highlight the potential connection between pseudotumor cerebri and the use of hormonal birth control was published in the New England Journal of Medicine in 1995. The study identified 56 cases where PTC side effects and optic disc edema occurred in women using oral contraceptives or intrauterine birth control implants, like the Mirena IUD. Most recently, at the 2015 meeting of the Association for Research in Vision and Ophthalmology, research findings were presented indicating that “exposure to a [levonorgestrel-releasing intrauterine system] was significantly associated with the development of [idiopathic intracranial hypertension],” and that the use of Bayer Healthcare’s Mirena IUD was “disproportionately more common among IIH patients than non-IIH patients.”

Pursuing Compensation for PTC Complications

The long-term effects of pseudotumor cerebri extend far beyond headaches and ringing in the ears, and may result in swelling of the optic nerve, which transmits visual information between the eyes and brain, possibly leading to permanent vision loss. Unfortunately, at this point, surgery is typically required to reduce the pressure around the optic nerve and relieve the buildup of pressure inside the skull. If you used a hormonal birth control product like Mirena IUD, and you have since suffered major side effects like pseudotumor cerebri or idiopathic intracranial hypertension, contact the knowledgeable PTC attorneys at the Monroe Law Group today for legal help. You may be entitled to financial compensation for your injuries, which you can pursue by filing a product liability lawsuit against the manufacturing company.

Alert: Due to statute of limitations, the time you have to pursue a Pseudotumor Cerebri claim is limited. Call us right away at 866-308-1092, email us at intake@monroelawgroup.com, or complete the form on this page now.

What is Onglyza?

Onglyza (saxagliptin) is a diabetes drug sold by AstraZeneca and Bristol-Myers Squibb, and commonly prescribed with diet and exercise to help control high blood sugar in adults with Type 2 diabetes. Onglyza was approved by the U.S. Food and Drug Administration (FDA) in 2009, and in 2014 alone, the medication brought in $820 million in sales for AstraZeneca and Bristol-Myers Squibb. The diabetes medication belongs to a class of drugs called DPP-4 (dipeptidyl peptidase-4) inhibitors, which are designed to help the pancreas secrete more insulin and inhibit the liver from making excess sugar.

Alleged Onglyza Side Effects

Since they first entered the market, DPP-4 inhibitors like Onglyza have been widely prescribed in the United States, and touted as the “new darlings of diabetes treatment.” However, serious concerns have emerged recently about the potential for Onglyza to cause severe side effects in users, including possibly increasing the risk of the following:

• Pancreatitis
• Pancreatic cancer
• Heart failure
• Severe joint pain
• Wrongful death

Studies Linking Onglyza to Side Effects

It wasn’t until 2011 that information about the risk of pancreatitis was added to the Onglyza warning label, after the FDA received post-market reports of patients suffering acute pancreatitis after taking the diabetes medication. Unfortunately, during the two years that Onglyza was on the market before that FDA warning was issued, Type 2 diabetes patients continued taking the DPP-4 inhibitor, unaware of the potential for the prescription drug to cause pancreatitis, a serious condition characterized by inflammation of the pancreas that can lead to hospitalization, pancreatic cancer and death.

In one study published in 2013, researchers found pre-cancerous cells in the autopsied pancreases of individuals taking incretin-based medications like Onglyza, and indicated that the use of DPP-4 inhibitors may be linked to the production of abnormal beta cells in the pancreas, as well as the development of small, benign tumors called adenomas that can become malignant. In another 2013 study, researchers found a possible connection between Onglyza treatment and an increased risk of heart failure, occurring when the heart pumps blood at a slower-than-normal rate, depriving the body of the oxygen it needs to survive.

In April 2015, an FDA panel recommended that new warnings be added to the Onglyza label regarding the potential increased risk of heart failure, citing data from the SAVOR clinical trial, which involved 16,492 patients and found that those taking Onglyza faced a 27% higher risk of heart failure hospitalizations, compared to the control group. Later that same year, the FDA issued a safety announcement warning that “the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling.”

Contact our experienced Onglyza legal team today

Hundreds of lawsuits have already been brought against the makers of Type 2 diabetes drugs like Onglyza, in connection with pancreatitis, pancreatic cancer, heart failure and other side effects, and more complaints are expected to be brought in the future, as more and more consumers become aware of the potential for Onglyza to cause devastating complications in users. If you have suffered pancreatitis, pancreatic cancer or another major medical complication, and you believe Onglyza to be the cause contact the Monroe Law Group today.

Alert: Due to statute of limitations, the time you have to pursue a claim is limited. Call us right away at 866-308-1092, email us at intake@monroelawgroup.com, or complete the form on this page now.

• Testosterone lawsuits are being filed due to dangerously high links to complications including heart attacks, strokes, pulmonary embolism, blood clots and death
• Attorneys believe that the manufacturers were aware of these links but continued to aggressively marketing these products in a case of profits over lives.
• Financial compensation may be available if you or a loved on has used one of these drugs and suffered an injury.

Otherwise healthy men who use testosterone therapies like AndroGel and Testim may be at risk for serious and potentially life-threatening medical consequences, like heart attack, stroke, blood clots and pulmonary embolism.

Unfortunately, because the makers of these medications have allegedly failed to provide adequate warnings about the risk of side effects from low-T treatments, men across the country with no medical need for testosterone therapy are putting themselves at an unnecessary risk for major complications by taking the drugs.

If you used a low-T treatment in the past, and you have since suffered a heart attack, stroke, or another serious medical condition, consult an experienced testosterone therapy attorney today to explore your possible compensation options.

Monroe Law Group – NO FEES UNLESS YOU WIN. You pay nothing until you win your case. Monroe Law Group pays for all costs of the lawsuit up front, and if don’t win, you pay nothing! If we win, you pay a percentage of the awarded settlement. Call 866-308-1092 now to speak with our team at no cost and no obligation.

What is Testosterone Replacement Therapy

Testosterone replacement therapy (TRT), also sometimes called testosterone therapy or “low-T’ treatment, is a type of medical treatment designed to help maintain a more uniform level of blood testosterone. Testosterone products like AndroGel, Testim and Fortesta are only approved to treat low testosterone levels in men diagnosed with hypogonadism, a condition occurring when the male gonads fail to function properly, but many healthy men have started testosterone replacement therapy in an effort to reverse the signs of the natural aging process, like erectile dysfunction, fatigue, decreased sex drive and loss of muscle mass. Low-T treatments can be administered in the form of a topical gel, a transdermal patch, an injection or the buccal system (applied to the inner cheek or upper gum).

Possible Side Effects of Low-T Treatment

Because there is limited data available regarding the safety and effectiveness of TRT for men who lack an associated medical condition, testosterone treatment has not been approved for this use, yet healthy men who have never had their testosterone levels properly tested continue to be prescribed low-T treatments like AndroGel and Testim. What many of these men don’t know, is that testosterone therapy has been linked to a potential increased risk of serious side effects in users, including:

• Heart attack
• Stroke
• Blood clots
• Pulmonary embolism
• Irregular heartbeat
• Deep vein thrombosis
• Decreased sperm production
• Wrongful death

Research Linking TRT to Serious Complications

In one study conducted by the National Cancer Institute in January 2014, researchers found that men over the age of 65, and men younger than 65 with a history of heart disease, had double the risk of suffering a heart attack within three months of starting testosterone replacement therapy. Another study published in the Journal of the American Medical Association in November 2013, found that older men faced a 29% increased risk of heart attack, stroke and death while using low-T treatments, further supporting the alleged link between testosterone therapy and potentially life-threatening side effects in men. It wasn’t until March 2015, that the FDA announced updated warning labels for all testosterone therapy products, highlighting the potential connection between low-T treatments and problems with heart attack and stroke. In the updated safety announcement, the FDA warned that “the benefit and safety of these medications have not been established for the treatment of low testosterone levels due to aging, even if a man’s symptoms seem related to low testosterone.”

Our Experienced Testosterone Therapy Legal Team Can Help

Alert: Due to statute of limitations, the time you have to pursue a Testosterone Therapy claim is limited. Call us right away at 866-308-1092, email us at intake@monroelawgroup.com, or complete the form on this page now.

How Does Xarelto Work?

Xarelto (rivaroxaban) is an anticoagulant medication sold by Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary, and used to prevent blood clots from forming in patients with atrial fibrillation or those undergoing knee or hip replacement surgery. Approved by the U.S. Food and Drug Administration (FDA) in 2011, Xarelto has been marketed by its manufacturers as a safer and more convenient alternative to warfarin, a blood thinner that has been on the market for decades. According to Bayer and Janssen, Xarelto is easier to take than warfarin and other older anticoagulant drugs, because it doesn’t require regular checkups or changes in diet and lifestyle during treatment.

What are the Possible Side Effects of Xarelto

Although Xarelto may require less patient monitoring than warfarin, the fact that the new-generation anticoagulant drug does not have an approved antidote makes it considerably more dangerous. Unlike warfarin, whose blood thinning effects can be reversed with a dose of vitamin K, there is no reversal agent for Xarelto, which means doctors may be unable to control internal bleeding complications in patients taking Xarelto, thereby increasing the risk of hospitalization or death. Among the possible side effects associated with Xarelto treatment are:

• Abdominal bleeding
• Internal bleeding
• Brain hemorrhage
• Abnormal liver function
• Gastrointestinal bleeding
• Hemorrhagic stroke
• Wrongful death

Studies Linking Xarelto to Complications

Although Xarelto is designed to prevent blood clots and blood clot-related injuries, adverse event reports submitted to the FDA in connection with Xarelto treatment indicate that patients taking the blood thinner may actually be at an increased risk for blood clots that may trigger heart attacks or strokes if they travel to the brain. In a Phase III study intended to analyze the safety of Xarelto, 73% of the 16,000 patients who took at least one dose of the blood thinner experienced serious side effects, including anemia and bleeding complications. The Xarelto drug label also currently carries a black box warning highlighting the risk of dangerous spinal bleeds called spinal hematomas, which can lead to permanent paralysis.

Researchers have been examining the possible safety risks of Xarelto for years. In 2011, the New England Journal of Medicine published the results of the ROCKET AF study, which compared Xarelto to warfarin in patients with atrial fibrillation. According to the FDA, the study failed to provide adequate evidence that Xarelto is a more effective treatment than warfarin, and the new-generation blood thinner is also known to cause more internal bleeding than its predecessor. In light of the potential for Xarelto cause serious bleeding complications, former Xarelto users across the country are pursuing legal claims against Bayer and Janssen, alleging that the drug makers manufactured a defective drug and failed to adequately warn consumers and doctors about its risks.

Contact our expert Xarelto legal team today for help

Alert: Due to statute of limitations, the time you have to pursue a Xarelto claim is limited. Call us right away at 866-308-1092, email us at intake@monroelawgroup.com, or complete the form on this page now.